1
|
Ahmed M, Zangos S, Bechstein WO and Vogl
TJ: Intravenous leiomyomatosis. Eur Radiol. 14:1316–1317. 2004.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Birch-Hirschfeld FV: Textbook of
pathological anatomy. FCW Vogel; Leipzig: pp. p2261896, (In
German).
|
3
|
Lim WH, Lamaro VP and Sivagnanam V:
Manifestation and management of intravenous leiomyomatosis: A
systematic review of the literature. Surg Oncol. 45:1018792022.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Findakly D and Wang J: Molecular profiling
of benign metastasizing leiomyoma of the uterus revealing unique
novel therapeutic targets. Cureus. 12:e77012020.PubMed/NCBI
|
5
|
Low HY, Zhao Y, Huang KS, Shen HP, Wu PJ
and Tseng CJ: Intravenous leiomyomatosis of the uterus: A
clinicopathological analysis of nine cases and literature review.
Taiwan J Obstet Gynecol. 56:362–365. 2017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kang LQ, Zhang B, Liu BG and Liu FH:
Diagnosis of intravenous leiomyomatosis extending to heart with
emphasis on magnetic resonance imaging. Chin Med J (Engl).
125:33–37. 2012.PubMed/NCBI
|
7
|
Shi P, Xiao H, Li H, Tang W, Ren A, Ma L,
Tu R, Yin S and Zhang J: Management and prognosis comparison
between incidental and nonincidental intravenous leiomyomatosis: A
retrospective single-center real-life experience. Ann Transl Med.
10:5032022. View Article : Google Scholar : PubMed/NCBI
|
8
|
Hayashi T, Yaegashi N and Konishi I:
Molecular pathological approach of uterine intravenous
leiomyomatosis. Ann Transl Med. 10:7242022. View Article : Google Scholar : PubMed/NCBI
|
9
|
Grimer RJ and Armstrong GR: Intra-vascular
leiomyoma of the popliteal vein. Postgrad Med J. 64:247–248. 1988.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Hansson B, Bogers J, Colpaert C, De Roeck
J, De Backer A, Ceulemans P, De Maeseneer M and Hubens G: Leiomyoma
of the right common iliac vein presenting as a duodenal tumour. Eur
J Surg Oncol. 26:717–719. 2000. View Article : Google Scholar : PubMed/NCBI
|
11
|
Fang H, You Y, Cai F, Yang Y, Yang C and
Lv P: Intravenous leiomyomatosis of the subclavian vein. J Vasc
Surg Venous Lymphat Disord. 5:254–256. 2017. View Article : Google Scholar : PubMed/NCBI
|
12
|
Gui T, Qian Q, Cao D, Yang J, Peng P and
Shen K: Computerized tomography angiography in preoperative
assessment of intravenous leiomyomatosis extending to inferior vena
cava and heart. BMC Cancer. 16:732016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Miro A, Bottazzi EC, Vanella S, Palma T,
Noviello A, Apicella I, Lombardi G, Fiorani B and Crafa F:
Intravascular leiomyomatosis with intracardiac extension: A
toraco-abdominal approach. J Surg Case Rep. 202:rjab2492021.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Ordulu Z, Nucci MR, Cin PD, Hollowell ML,
Otis CN, Hornick JL, Park PJ, Kim TM, Quade BJ and Morton CC:
Intravenous leiomyomatosis: An unusual intermediate between benign
and malignant uterine smooth muscle tumors. Mod Pathol. 29:500–510.
2016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhang X, Wu L, Xu R, Zhu C, Ma G, Zhang C,
Liu X, Zhao H and Miao Q: Identification of the molecular
relationship between intravenous leiomyomatosis and uterine myoma
using RNA sequencing. Sci Rep. 9:14422019. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wang W, Wang Y, Chen F, Zhang M, Jia R,
Liu X, Zhang C, Shao J, Cheng N, Ma G, et al: Intravenous
leiomyomatosis is inclined to a solid entity different from uterine
leiomyoma based on RNA-seq analysis with RT-qPCR validation. Cancer
Med. 9:4581–4592. 2020. View Article : Google Scholar : PubMed/NCBI
|
17
|
Rein MS, Friedman AJ, Barbieri RL, Pavelka
K, Fletcher JA and Morton CC: Cytogenetic abnormalities in uterine
leiomyomata. Obstet Gynecol. 77:923–926. 1991.PubMed/NCBI
|
18
|
Schoenmakers EF, Wanschura S, Mols R,
Bullerdiek J, Van den Berghe H and Van de Ven WJ: Recurrent
rearrangements in the high mobility group protein gene, HMGI-C, in
benign mesenchymal tumours. Nat Genet. 10:436–444. 1995. View Article : Google Scholar : PubMed/NCBI
|
19
|
Ordulu Z, Chai H, Peng G, McDonald AG, De
Nictolis M, Garcia-Fernandez E, Hardisson D, Prat J, Li P, Hui P,
et al: Molecular and clinicopathologic characterization of
intravenous leiomyomatosis. Mod Pathol. 33:1844–1860. 2020.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Buza N, Xu F, Wu W, Carr RJ, Li P and Hui
P: Recurrent chromosomal aberrations in intravenous leiomyomatosis
of the uterus: High-resolution array comparative genomic
hybridization study. Hum Pathol. 45:1885–1892. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Matsubara A, Sekine S, Yoshida M, Yoshida
A, Taniguchi H, Kushima R, Tsuda H and Kanai Y: Prevalence of MED12
mutations in uterine and extrauterine smooth muscle tumours.
Histopathology. 62:657–661. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang L, Hu S, Xin F, Zhao H, Li G, Ran W,
Xing X and Wang J: MED12 exon 2 mutation is uncommon in intravenous
leiomyomatosis: Clinicopathologic features and molecular study. Hum
Pathol. 99:36–42. 2020. View Article : Google Scholar : PubMed/NCBI
|
23
|
Krasny L, Wilding CP, Perkins E, Arthur A,
Guljar N, Jenks AD, Fisher C, Judson I, Thway K, Jones RL and Huang
PH: Proteomic profiling identifies co-regulated expression of
splicing factors as a characteristic feature of intravenous
leiomyomatosis. Cancers (Basel). 14:29072022. View Article : Google Scholar : PubMed/NCBI
|
24
|
Cassol DF, Junior FJRT, Dias do Couto
Netto S, Rengel LC, Ragazzo L, Gaiotto FA and Utiyama EM:
Symptomatic uterine leiomyomatosis with intracaval and intracardiac
invasion: Video case report. Gynecol Oncol Rep. 45:1011272023.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Lan S, Wang X, Li Y and Zhai M:
Intravenous leiomyomatosis: A case study and literature review.
Radiol Case Rep. 17:4203–4208. 2022. View Article : Google Scholar : PubMed/NCBI
|
26
|
Peng J, Zhong F, Zhu Y, Zhang M, Zhang M,
Lu C, Wang Y, Qi X, Wang C and Li G: Clinical analysis of uterine
intravenous leiomyomatosis: A retrospective study of 260 cases. J
Obstet Gynaecol Res. 47:4357–4364. 2021. View Article : Google Scholar : PubMed/NCBI
|
27
|
Jin X, Li F, Lu Z and Cheng W: IV
Leiomyomatosis on FDG PET/CT. Clin Nucl Med. 41:580–582. 2016.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Barksdale J, Abolhoda A and Saremi F:
Intravenous leiomyomatosis presenting as acute Budd-Chiari
syndrome. J Vasc Surg. 54:860–863. 2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Deng Y and Song B: Three case reports of
intravenous leiomyomatosis with intracardiac extensions. Thorac
Cardiovasc Surg Rep. 9:e40–e43. 2020. View Article : Google Scholar : PubMed/NCBI
|
30
|
Luo X, Li R and Li Z: Combined
transthoracic echocardiography and contrast-enhanced
ultrasonography to trace intravenous leiomyomatosis with
intracardiac extension. Echocardiography. 36:1573–1576. 2019.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Lam PM, Lo KW, Yu MY, Wong WS, Lau JY,
Arifi AA and Cheung TH: Intravenous leiomyomatosis: Two cases with
different routes of tumor extension. J Vasc Surg. 39:465–469. 2004.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Zhang G, Yu X, Shi H, Fan Q, Lang J and
Liu B: Clinical characteristics and prognostic features of
intravenous leiomyomatosis with inferior vena cava or intracardiac
extension. J Vasc Surg Venous Lymphat Disord. 5:485–492. 2017.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Ma H, Niu Y, Yang Z and Zheng M:
Echocardiographic characteristics and contrast-enhanced imaging of
intravenous leiomyomatosis with intracardiac extension. J
Ultrasound Med. 41:1101–1108. 2022. View Article : Google Scholar : PubMed/NCBI
|
34
|
Ge Z, Wang Y, Wang Y, Fang S, Wang H and
Li J: Diagnostic value of contrast-enhanced ultrasound in
intravenous leiomyomatosis: A single-center experiences. Front
Oncol. 12:9636752022. View Article : Google Scholar : PubMed/NCBI
|
35
|
Wang H, Nie P, Chen B, Hou F, Dong C, He F
and Xu W: Contrast-enhanced CT findings of intravenous
leiomyomatosis. Clin Radiol. 73:503e1–503e6. 2018. View Article : Google Scholar : PubMed/NCBI
|
36
|
Peng HJ, Zhao B, Yao QW, Qi HT, Xu ZD and
Liu C: Intravenous leiomyomatosis: CT findings. Abdom Imaging.
37:628–631. 2012. View Article : Google Scholar : PubMed/NCBI
|
37
|
Zeng H, Xu Z, Zhang L, Luo YI, Chen H, Zhu
H, Peng L and Yu J: Intravenous leiomyomatosis with intracardiac
extension depicted on computed tomography and magnetic resonance
imaging scans: A report of two cases and a review of the
literature. Oncol Lett. 11:4255–4263. 2016. View Article : Google Scholar : PubMed/NCBI
|
38
|
Shao J, Wang C, Shu K, Zhou Y, Cheng N,
Lai Z, Li K, Xu L, Chen J, Du F, et al: A contrast-enhanced
CT-based radiomic nomogram for the differential diagnosis of
intravenous leiomyomatosis and uterine leiomyoma. Front Oncol.
13:12391242023. View Article : Google Scholar : PubMed/NCBI
|
39
|
Yu X, Fu J, Cao T, Huang L, Qie M and
Ouyang Y: Clinicopathologic features and clinical outcomes of
intravenous leiomyomatosis of the uterus: A case series. Medicine
(Baltimore). 100:e242282021. View Article : Google Scholar : PubMed/NCBI
|
40
|
Wei JL, Ji X, Zhang P, Chen WJ, Zhao YN
and Liu M: Complete intravenous leiomyomatosis: A case report and
literature review. Ann Palliat Med. 10:12039–12045. 2021.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Du J, Zhao X, Guo D, Li H and Sun B:
Intravenous leiomyomatosis of the uterus: A clinicopathologic study
of 18 cases, with emphasis on early diagnosis and appropriate
treatment strategies. Hum Pathol. 42:1240–1246. 2011. View Article : Google Scholar : PubMed/NCBI
|
42
|
Bartolazzi A, Peach R, Aruffo A and
Stamenkovic I: Interaction between CD44 and hyaluronate is directly
implicated in the regulation of tumor development. J Exp Med.
180:53–66. 1994. View Article : Google Scholar : PubMed/NCBI
|
43
|
Chen MJ, Peng Y, Yang YS, Huang SC, Chow
SN and Torng PL: Increased hyaluronan and CD44 expressions in
intravenous leiomyomatosis. Acta Obstet Gynecol Scand. 84:322–328.
2005. View Article : Google Scholar : PubMed/NCBI
|
44
|
Tamura S, Hayashi T, Tokunaga H, Yaegashi
N, Abiko K and Konishi I: Oncological properties of intravenous
leiomyomatosis: Involvement of mesenchymal tumor stem-like cells.
Curr Issues Mol Biol. 43:1188–1202. 2021. View Article : Google Scholar : PubMed/NCBI
|
45
|
Sherr CJ and McCormick F: The RB and p53
pathways in cancer. Cancer Cell. 2:103–112. 2002. View Article : Google Scholar : PubMed/NCBI
|
46
|
Peurala E, Koivunen P, Haapasaari KM,
Bloigu R and Jukkola-Vuorinen A: The prognostic significance and
value of cyclin D1, CDK4 and p16 in human breast cancer. Breast
Cancer Res. 15:R52013. View Article : Google Scholar : PubMed/NCBI
|
47
|
Sungur EC, Selçuk İ, Özbek HM, Aytekin O,
Köklü NO, Turhan N, Talay S, Sarıtaş A and Yalçın HR: Extrapelvic
intravenous uterine leiomyomatosis mimicing cardiac myxoma and deep
vein thrombosis. Turk Gogus Kalp Damar Cerrahisi Derg. 30:622–626.
2022. View Article : Google Scholar : PubMed/NCBI
|
48
|
Yokoyama Y, Goda T, Sato K, Suzuki M,
Kanda T and Sato Y: Leiomyosarcoma arising from the ovarian vein as
a gynecologic malignancy: Two case reports and a review of the
literature. J Obstet Gynaecol Res. 48:2224–2230. 2022. View Article : Google Scholar : PubMed/NCBI
|
49
|
Li B, Chen X, Chu YD, Li RY, Li WD and Ni
YM: Intracardiac leiomyomatosis: A comprehensive analysis of 194
cases. Interact Cardiovasc Thorac Surg. 17:132–138. 2013.
View Article : Google Scholar : PubMed/NCBI
|
50
|
Liang J, Lei R, Xie M, Lin S, Xu J, Ling X
and Xie Q: The role of estrogen deprivation therapy in
premenopausal women with primary unresectable intracardiac
leiomyomatosis: A systematic review and meta-analysis. Orphanet J
Rare Dis. 16:4532021. View Article : Google Scholar : PubMed/NCBI
|
51
|
Li H, Xu J, Lin Q, Zhang Y, Zhao Y, Tong
H, Tu R, Xu D, Wang C and Lu W: Surgical treatment strategies for
extra-pelvic intravenous leiomyomatosis. Orphanet J Rare Dis.
15:1532020. View Article : Google Scholar : PubMed/NCBI
|
52
|
Stilidi I, Paianidi J, Bokhian V, Andreeva
J, Shevchuk A and Ramirez PT: Intracardiac intravenous
leiomyomatosis: Diagnosis and management. Int J Gynecol Cancer.
30:1243–1247. 2020. View Article : Google Scholar : PubMed/NCBI
|
53
|
Ma G, Miao Q, Liu X, Zhang C, Liu J, Zheng
Y, Shao J, Cheng N, Du S, Hu Z, et al: Different surgical
strategies of patients with intravenous leiomyomatosis. Medicine
(Baltimore). 95:e49022016. View Article : Google Scholar : PubMed/NCBI
|
54
|
Yang C, Fang H, Yang Y, Cai F, Zheng H,
Jin B, Li Y, Liu Z and Zayed MA: Diagnosis and surgical management
of inferior vena cava leiomyomatosis. J Vasc Surg Venous Lymphat
Disord. 6:636–645. 2018. View Article : Google Scholar : PubMed/NCBI
|
55
|
Gissey LC, Mariano G, Musleh L, Lepiane P,
Colasanti M, Meniconi RL, Ranocchi F, Musumeci F, Antonini M and
Ettorre GM: Massive pelvic recurrence of uterine leiomyomatosis
with intracaval-intracardiac extension: Video case report and
literature review. BMC Surg. 17:1182017. View Article : Google Scholar : PubMed/NCBI
|
56
|
Luo G, Pan H, Bi J, Luo Y, Zhu J, Feng Z,
Fan H, Zhang Y and Dai X: Surgical treatment of intravenous
leiomyomatosis involving the right heart: A case series. J Int Med
Res. 47:3465–3474. 2019. View Article : Google Scholar : PubMed/NCBI
|
57
|
Price JD, Anagnostopoulos C, Benvenisty A,
Kothuru RK and Balaram SK: Intracardiac extension of intravenous
leiomyomatosis. Ann Thorac Surg. 103:e145–e147. 2017. View Article : Google Scholar : PubMed/NCBI
|
58
|
Wang C, Shao J, Ma X, Zhou Y, Ma G, Cheng
N, Cao D, Lai Z, Song X, Li K and Liu B: One-stage resection of
intravascular leiomyomatosis involving the right heart chamber
through a single laparotomy. Front Cardiovasc Med. 9:9764782022.
View Article : Google Scholar : PubMed/NCBI
|
59
|
Liu J, Liang M, Ma G, Liu X, Cheng N, Cao
D, Yu C, Du S, Miao Q and Zhang C: Surgical treatment for
intravenous-cardiac leiomyomatosis. Eur J Cardiothorac Surg.
54:483–490. 2018. View Article : Google Scholar : PubMed/NCBI
|
60
|
Kokawa K, Yamoto M, Yata C, Mabuchi Y and
Umesaki N: Postmenopausal intravenous leiomyomatosis with high
levels of estradiol and estrogen receptor. Obstet Gynecol.
100:1124–1126. 2002. View Article : Google Scholar : PubMed/NCBI
|
61
|
Akinseye OA, Nayyar M and Das P: Uterine
intravenous leiomyomatosis with femoral vein, intracaval,
intracardiac and pulmonary artery extension. Future Cardiol.
16:27–32. 2020. View Article : Google Scholar : PubMed/NCBI
|
62
|
Mitsuhashi A, Nagai Y, Sugita M, Nakajima
N and Sekiya S: GnRH agonist for intravenous leiomyomatosis with
cardiac extension. A case report. J Reprod Med. 44:883–886.
1999.PubMed/NCBI
|
63
|
Khayata GM, Thwaini S and Aswad SG:
Intravenous leiomyomatosis extending to the heart. Int J Gynaecol
Obstet. 80:59–60. 2003. View Article : Google Scholar : PubMed/NCBI
|
64
|
Mizoguchi C, Matsumoto H, Nasu K, Arakane
M, Kai K and Narahara H: Intravenous leiomyomatosis treated with
radical hysterectomy and adjuvant aromatase inhibitor therapy. J
Obstet Gynaecol Res. 42:1405–1408. 2016. View Article : Google Scholar : PubMed/NCBI
|
65
|
Bodner-Adler B, Bartl M and Wagner G:
Intravenous leiomyomatosis of the uterus with pulmonary metastases
or a case with benign metastasizing leiomyoma? Anticancer Res.
29:495–496. 2009.PubMed/NCBI
|
66
|
Hameleers JA, Zeebregts CJ, Hamerlijnck
RP, Elbers JR and Hameeteman TM: Combined surgical and medical
approach to intravenous leiomyomatosis with cardiac extension. Acta
Chir Belg. 99:92–94. 1999. View Article : Google Scholar : PubMed/NCBI
|
67
|
Doyle MP, Li A, Villanueva CI, Peeceeyen
SC, Cooper MG, Hanel KC, Fermanis GG and Robertson G: Treatment of
intravenous leiomyomatosis with cardiac extension following
incomplete resection. Int J Vasc Med. 2015:7561412015.PubMed/NCBI
|
68
|
Lo KW and Lau TK: Intracardiac
leiomyomatosis. Case report and literature review. Arch Gynecol
Obstet. 264:209–210. 2001. View Article : Google Scholar : PubMed/NCBI
|
69
|
Yu X, Zhang G, Lang J, Liu B and Zhao D:
Factors associated with recurrence after surgical resection in
women with intravenous leiomyomatosis. Obstet Gynecol.
128:1018–1024. 2016. View Article : Google Scholar : PubMed/NCBI
|